USFDA concludes inspection of Indoco's Sterile facility (Plant II)

The US Food and Drug Administration (USFDA) conducted audit at Indoco's sterile manufacturing facility in Verna, Goa (Plant II) from 27th May'19 to 4th June'19, issuing 4 observations (483s). These observations are procedural in nature, not pertaining to data integrity. The Company will submit its responses shortly.

Powered by Capital Market - Live News